{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T07:20:30Z","timestamp":1778570430092,"version":"3.51.4"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,1,8]],"date-time":"2016-01-08T00:00:00Z","timestamp":1452211200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,1,8]],"date-time":"2016-01-08T00:00:00Z","timestamp":1452211200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000056","name":"National Institute of Nursing Research","doi-asserted-by":"publisher","award":["T32 NR07102"],"award-info":[{"award-number":["T32 NR07102"]}],"id":[{"id":"10.13039\/100000056","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000056","name":"National Institute of Nursing Research","doi-asserted-by":"publisher","award":["F31 NR07556"],"award-info":[{"award-number":["F31 NR07556"]}],"id":[{"id":"10.13039\/100000056","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIH\/NINR; Oncology Nursing Society\/Ortho-Biotech; PEO Scholar Award","award":["F31NR007556"],"award-info":[{"award-number":["F31NR007556"]}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA047904"],"award-info":[{"award-number":["P30 CA047904"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s00520-015-3071-4","type":"journal-article","created":{"date-parts":[[2016,1,8]],"date-time":"2016-01-08T04:04:46Z","timestamp":1452225886000},"page":"2635-2642","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Nausea as a sentinel symptom for cytotoxic chemotherapy effects on the gut-brain axis among women receiving treatment for recurrent ovarian cancer: an exploratory analysis"],"prefix":"10.1007","volume":"24","author":[{"given":"Heidi S.","family":"Donovan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa L.","family":"Hagan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace B.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle M.","family":"Boisen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leah M.","family":"Rosenblum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert P.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dana H.","family":"Bovbjerg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles C.","family":"Horn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,1,8]]},"reference":[{"key":"3071_CR1","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/S0899-9007(00)00464-0","volume":"16","author":"GJ Schwartz","year":"2000","unstructured":"Schwartz GJ (2000) The role of gastrointestinal vagal afferents in the control of food intake: current prospects. Nutrition 16:866\u2013873","journal-title":"Nutrition"},{"key":"3071_CR2","first-page":"287","volume":"122","author":"NS Track","year":"1980","unstructured":"Track NS (1980) The gastrointestinal endocrine system. Can Med Assoc J 122:287\u2013292","journal-title":"Can Med Assoc J"},{"key":"3071_CR3","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/nrn3346","volume":"13","author":"JF Cryan","year":"2012","unstructured":"Cryan JF, Dinan TG (2012) Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci 13:701\u2013712","journal-title":"Nat Rev Neurosci"},{"key":"3071_CR4","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1177\/0004867415569801","volume":"49","author":"PC Keightley","year":"2015","unstructured":"Keightley PC, Koloski NA, Talley NJ (2015) Pathways in gut-brain communication: evidence for distinct gut-to-brain and brain-to-gut syndromes. Aust N Z J Psychiatry 49:207\u2013214","journal-title":"Aust N Z J Psychiatry"},{"key":"3071_CR5","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nrgastro.2009.35","volume":"6","author":"SH Rhee","year":"2009","unstructured":"Rhee SH, Pothoulakis C, Mayer EA (2009) Principles and clinical implications of the brain\u2013gut\u2013enteric microbiota axis. Nat Rev Gastroenterol Hepatol 6:306\u2013314","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3071_CR6","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.2174\/1871527313666141130205242","volume":"13","author":"A Slyepchenko","year":"2014","unstructured":"Slyepchenko A, Carvalho AF, Cha DS, Kasper S, McIntyre RS (2014) Gut emotions-mechanisms of action of probiotics as novel therapeutic targets for depression and anxiety disorders. CNS Neurol Disord Drug Targets 13:1770\u20131786","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"3071_CR7","doi-asserted-by":"publisher","first-page":"7067","DOI":"10.1523\/JNEUROSCI.0252-14.2014","volume":"34","author":"M Klarer","year":"2014","unstructured":"Klarer M, Arnold M, G\u00fcnther L et al (2014) Gut vagal afferents differentially modulate innate anxiety and learned fear. J Neurosci 34:7067\u20137076","journal-title":"J Neurosci"},{"key":"3071_CR8","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.tins.2013.01.005","volume":"36","author":"JA Foster","year":"2013","unstructured":"Foster JA, Neufeld KAM (2013) Gut\u2013brain axis: how the microbiome influences anxiety and depression. Trends Neurosci 36:305\u2013312","journal-title":"Trends Neurosci"},{"key":"3071_CR9","doi-asserted-by":"publisher","first-page":"404","DOI":"10.4161\/gmic.29232","volume":"5","author":"K Tillisch","year":"2014","unstructured":"Tillisch K (2014) The effects of gut microbiota on CNS function in humans. Gut Microbes 5:404\u2013410","journal-title":"Gut Microbes"},{"key":"3071_CR10","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.lfs.2014.07.009","volume":"111","author":"K Miyazaki","year":"2014","unstructured":"Miyazaki K, Itoh N, Yamamoto S et al (2014) Dietary heat-killed Lactobacillus brevis SBC8803 promotes voluntary wheel-running and affects sleep rhythms in mice. Life Sci 111:47\u201352","journal-title":"Life Sci"},{"key":"3071_CR11","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.neuroscience.2013.02.055","volume":"240","author":"S Davari","year":"2013","unstructured":"Davari S, Talaei SA, Alaei H (2013) Probiotics treatment improves diabetes-induced impairment of synaptic activity and cognitive function: behavioral and electrophysiological proofs for microbiome\u2013gut\u2013brain axis. Neuroscience 240:287\u2013296","journal-title":"Neuroscience"},{"key":"3071_CR12","doi-asserted-by":"publisher","first-page":"15490","DOI":"10.1523\/JNEUROSCI.3299-14.2014","volume":"34","author":"EA Mayer","year":"2014","unstructured":"Mayer EA, Knight R, Mazmanian SK, Cryan JF, Tillisch K (2014) Gut microbes and the brain: paradigm shift in neuroscience. J Neurosci 34:15490\u201315496","journal-title":"J Neurosci"},{"key":"3071_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1757-4749-1-6","volume":"1","author":"AV Rao","year":"2009","unstructured":"Rao AV, Bested AC, Beaulne TM et al (2009) A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome. Gut Pathog 1:1\u20136","journal-title":"Gut Pathog"},{"key":"3071_CR14","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.1113\/jphysiol.2014.273995","volume":"15","author":"G De Palma","year":"2014","unstructured":"De Palma G, Collins SM, Bercik P, Verdu EF (2014) The microbiota-gut-brain axis in gastrointestinal disorders: stressed bugs, stressed brain or both? J Physiol 15:2989\u20132997","journal-title":"J Physiol"},{"key":"3071_CR15","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3747\/co.2007.148","volume":"14","author":"M Fung-Kee-Fung","year":"2007","unstructured":"Fung-Kee-Fung M, Oliver T, Elit L et al (2007) Optimal chemotherapy treatment for women with recurrent ovarian cancer. Curr Oncol 14:195\u2013208","journal-title":"Curr Oncol"},{"key":"3071_CR16","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrc2167","volume":"7","author":"L Kelland","year":"2007","unstructured":"Kelland L (2007) The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer 7:573\u2013584","journal-title":"Nat Rev Cancer"},{"key":"3071_CR17","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1177\/1758834014544121","volume":"6","author":"D Luvero","year":"2014","unstructured":"Luvero D, Milani A, Ledermann JA (2014) Treatment options in recurrent ovarian cancer: latest evidence and clinical potential. Ther Adv Med Oncol 6:229\u2013239","journal-title":"Ther Adv Med Oncol"},{"key":"3071_CR18","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1056\/NEJMra0706547","volume":"358","author":"PJ Hesketh","year":"2008","unstructured":"Hesketh PJ (2008) Chemotherapy-induced nausea and vomiting. N Engl J Med 358:2482\u20132494","journal-title":"N Engl J Med"},{"key":"3071_CR19","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1200\/JCO.1995.13.12.2961","volume":"13","author":"P Francis","year":"1995","unstructured":"Francis P, Rowinsky E, Schneider J et al (1995) Phase I feasibility and pharmacologic study of weekly intraperitoneal paclitaxel: a Gynecologic Oncology Group pilot study. J Clin Oncol 13:2961\u20132967","journal-title":"J Clin Oncol"},{"key":"3071_CR20","doi-asserted-by":"publisher","first-page":"4189","DOI":"10.1200\/JCO.2010.34.4614","volume":"29","author":"E Basch","year":"2011","unstructured":"Basch E, Prestrud AA, Hesketh PJ et al (2011) Antiemetics: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 29:4189\u20134198","journal-title":"J Clin Oncol"},{"key":"3071_CR21","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ejphar.2013.10.015","volume":"722","author":"D Warr","year":"2014","unstructured":"Warr D (2014) Prognostic factors for chemotherapy induced nausea and vomiting. Eur J Pharmacol 722:192\u2013196","journal-title":"Eur J Pharmacol"},{"key":"3071_CR22","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s00520-006-0173-z","volume":"15","author":"L Cohen","year":"2007","unstructured":"Cohen L, de Moor CA, Eisenberg P, Ming EE, Hu H (2007) Chemotherapy-induced nausea and vomiting\u2014incidence and impact on patient quality of life at community oncology settings. Support Care Cancer 15:497\u2013503","journal-title":"Support Care Cancer"},{"key":"3071_CR23","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.1007\/s00520-012-1448-1","volume":"20","author":"P Fernandez-Ortega","year":"2012","unstructured":"Fernandez-Ortega P, Caloto MT, Chirveches E et al (2012) Chemotherapy-induced nausea and vomiting in clinical practice: impact on patients\u2019 quality of life. Support Care Cancer 20:3141\u20133148","journal-title":"Support Care Cancer"},{"key":"3071_CR24","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.jpainsymman.2007.04.017","volume":"35","author":"HS Donovan","year":"2008","unstructured":"Donovan HS, Ward S, Sherwood P, Serlin RC (2008) Evaluation of the symptom representation questionnaire (SRQ) for assessing cancer-related symptoms. J Pain Symptom Manag 35:242\u2013257","journal-title":"J Pain Symptom Manag"},{"key":"3071_CR25","unstructured":"National Comprehensive Cancer Network (2015) NCCN Clinical Practice Guidelines in Oncology; v.2: Antiemesis. Available at: \n                    http:\/\/www.nccn.org\/professionals\/physician_gls\/PDF\/antiemesis.pdf\n                    \n                  . Accessed 4 Dec 2015"},{"key":"3071_CR26","volume-title":"Handbook of biological statistics","author":"JH McDonald","year":"2014","unstructured":"McDonald JH (2014) Handbook of biological statistics, 3rd edn. Sparky House Publishing, Baltimore","edition":"3"},{"key":"3071_CR27","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1471-2407-13-6","volume":"13","author":"JK Cataldo","year":"2013","unstructured":"Cataldo JK, Paul S, Cooper B et al (2013) Differences in the symptom experience of older versus younger oncology outpatients: a cross-sectional study. BMC Cancer 13:6","journal-title":"BMC Cancer"},{"key":"3071_CR28","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jpainsymman.2014.12.011","volume":"50","author":"C Miaskowski","year":"2015","unstructured":"Miaskowski C, Dunn L, Ritchie C et al (2015) Latent class analysis reveals distinct subgroups of patients based on symptom occurrence and demographic and clinical characteristics. J Pain Symptom Manag 50:28\u201337","journal-title":"J Pain Symptom Manag"},{"key":"3071_CR29","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.jpainsymman.2013.05.017","volume":"47","author":"C Ritchie","year":"2014","unstructured":"Ritchie C, Dunn LB, Paul SM et al (2014) Differences in the symptom experience of older oncology outpatients. J Pain Symptom Manag 47:697\u2013709","journal-title":"J Pain Symptom Manag"},{"key":"3071_CR30","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/s00520-009-0723-2","volume":"18","author":"JA Roscoe","year":"2010","unstructured":"Roscoe JA, Morrow GR, Colagiuri B et al (2010) Insight in the prediction of chemotherapy-induced nausea. Support Care Cancer 18:869\u2013876","journal-title":"Support Care Cancer"},{"key":"3071_CR31","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1186\/1471-2407-14-758","volume":"14","author":"JM Giesinger","year":"2014","unstructured":"Giesinger JM, Wintner LM, Zabernigg A et al (2014) Assessing quality of life on the day of chemotherapy administration underestimates patients\u2019 true symptom burden. BMC Cancer 14:758","journal-title":"BMC Cancer"},{"key":"3071_CR32","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2407-12-77","volume":"12","author":"V Meraner","year":"2012","unstructured":"Meraner V, Gamper EM, Grahmann A et al (2012) Monitoring physical and psychosocial symptom trajectories in ovarian cancer patients receiving chemotherapy. BMC Cancer 12:77","journal-title":"BMC Cancer"},{"key":"3071_CR33","unstructured":"Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (1975) SEER Cancer Statistics Review. National Cancer Institute. Bethesda \n                    http:\/\/seer.cancer.gov\/csr\/1975_2012\/\n                    \n                  , based on November 2014 SEER data submission, posted to the SEER web site, April 2015. Ovarian cancer statistics accessed at \n                    http:\/\/seer.cancer.gov\/statfacts\/html\/ovary.html\n                    \n                   Accessed 04 Dec 2015."},{"key":"3071_CR34","unstructured":"National Comprehensive Cancer Network (2015) NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): Ovarian cancer: including fallopian tube cancer and primary peritoneal cancer. Version 2.2015. \n                    http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/ovarian.pdf\n                    \n                  . Accessed 13 Aug 15."},{"key":"3071_CR35","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nrn3071","volume":"12","author":"EA Mayer","year":"2011","unstructured":"Mayer EA (2011) Gut feelings: the emerging biology of gut-brain communication. Nat Rev Neurosci 12:453\u2013466","journal-title":"Nat Rev Neurosci"},{"key":"3071_CR36","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.ygyno.2007.06.010","volume":"107","author":"LM Hess","year":"2007","unstructured":"Hess LM, Barakat R, Tian C, Ozols RF, Alberts DS (2007) Weight change during chemotherapy as a potential prognostic factor for stage III epithelial ovarian carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 107:260\u2013265","journal-title":"Gynecol Oncol"},{"key":"3071_CR37","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3109\/00016340903322735","volume":"89","author":"I Sk\u00edrnisd\u00f3ttir","year":"2010","unstructured":"Sk\u00edrnisd\u00f3ttir I, Sorbe B (2010) Body mass index as a prognostic factor in epithelial ovarian cancer and correlation with clinico\u2010pathological factors. Acta Obstet Gynecol Scand 89:101\u2013107","journal-title":"Acta Obstet Gynecol Scand"},{"key":"3071_CR38","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/j.1447-0756.2011.01628.x","volume":"38","author":"DH Suh","year":"2012","unstructured":"Suh DH, Kim HS, Chung HH et al (2012) Body mass index and survival in patients with epithelial ovarian cancer. J Obstet Gynaecol Res 38:70\u201376","journal-title":"J Obstet Gynaecol Res"},{"key":"3071_CR39","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.ygyno.2009.11.009","volume":"116","author":"JL Lesnock","year":"2010","unstructured":"Lesnock JL, Richard SD, Zorn KK et al (2010) Completion of intraperitoneal chemotherapy in advanced ovarian cancer and catheter-related complications. Gynecol Oncol 116:345\u2013350","journal-title":"Gynecol Oncol"},{"key":"3071_CR40","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1056\/NEJMoa052985","volume":"354","author":"DK Armstrong","year":"2006","unstructured":"Armstrong DK, Bundy B, Wenzel L et al (2006) Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med 354:34\u201343","journal-title":"N Engl J Med"},{"key":"3071_CR41","first-page":"413","volume":"4","author":"DL Chan","year":"2012","unstructured":"Chan DL, Morris DL, Rao A, Chua TC (2012) Intraperitoneal chemotherapy in ovarian cancer: a review of tolerance and efficacy. Cancer Manag Res 4:413\u2013422","journal-title":"Cancer Manag Res"},{"key":"3071_CR42","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/978-1-4939-0897-4_5","volume":"817","author":"P Forsythe","year":"2014","unstructured":"Forsythe P, Bienenstock J, Kunze WA (2014) Vagal pathways for microbiome-brain-gut axis communication. Adv Exp Med Biol 817:115\u2013133","journal-title":"Adv Exp Med Biol"},{"issue":"Suppl 1","key":"3071_CR43","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/j.1365-2982.2008.01104.x","volume":"20","author":"HR Berthoud","year":"2008","unstructured":"Berthoud HR (2008) Vagal and hormonal gut-brain communication: from satiation to satisfaction. Neurogastroenterol Motil 20(Suppl 1):64\u201372","journal-title":"Neurogastroenterol Motil"},{"key":"3071_CR44","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1007\/s00221-014-3985-y","volume":"232","author":"CC Horn","year":"2014","unstructured":"Horn CC (2014) Measuring the nausea-to-emesis continuum in non-human animals: refocusing on gastrointestinal vagal signaling. Exp Brain Res 232:2471\u20132481","journal-title":"Exp Brain Res"},{"key":"3071_CR45","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.mehy.2013.05.034","volume":"81","author":"MB VanElzakker","year":"2013","unstructured":"VanElzakker MB (2013) Chronic fatigue syndrome from vagus nerve infection: a psychoneuroimmunological hypothesis. Med Hypotheses 81:414\u2013423","journal-title":"Med Hypotheses"},{"key":"3071_CR46","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/psyp.12333","volume":"52","author":"HJ Tsai","year":"2015","unstructured":"Tsai HJ, Kuo TB, Lee GS, Yang CC (2015) Efficacy of paced breathing for insomnia: enhances vagal activity and improves sleep quality. Psychophysiology 52:388\u2013396","journal-title":"Psychophysiology"},{"key":"3071_CR47","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.autneu.2014.07.008","volume":"185","author":"R Laqua","year":"2014","unstructured":"Laqua R, Leutzow B, Wendt M, Usichenko T (2014) Transcutaneous vagal nerve stimulation may elicit anti- and pro-nociceptive effects under experimentally-induced pain\u2014a crossover placebo-controlled investigation. Auton Neurosci 185:120\u2013122","journal-title":"Auton Neurosci"},{"key":"3071_CR48","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.neulet.2009.08.075","volume":"465","author":"N Percie du Sert","year":"2009","unstructured":"Percie du Sert N, Rudd JA, Moss R, Andrews PL (2009) The delayed phase of cisplatin-induced emesis is mediated by the area postrema and not the abdominal visceral innervation in the ferret. Neurosci Lett 465:16\u201320","journal-title":"Neurosci Lett"},{"key":"3071_CR49","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s00280-010-1519-2","volume":"68","author":"T Takahashi","year":"2011","unstructured":"Takahashi T, Nakamura Y, Tsuya A, Murakami H, Endo M, Yamamoto N (2011) Pharmacokinetics of aprepitant and dexamethasone after administration of chemotherapeutic agents and effects of plasma substance P concentration on chemotherapy-induced nausea and vomiting in Japanese cancer patients. Cancer Chemother Pharmacol 68:653\u2013659","journal-title":"Cancer Chemother Pharmacol"},{"key":"3071_CR50","doi-asserted-by":"crossref","unstructured":"Higa GM, Auber ML, Altaha R, Piktel D, Kurian S, Hobbs G, Landreth K (2006) 5-Hydroxyindoleacetic acid and substance P profiles in patients receiving emetogenic chemotherapy. J Oncol Pharm Pract 12: 201\u20139. Erratum in: J Oncol Pharm Pract 2007 13(1):59\u201360","DOI":"10.1177\/1078155206072080"},{"key":"3071_CR51","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1200\/JCO.1999.17.9.2971","volume":"17","author":"RJ Gralla","year":"1999","unstructured":"Gralla RJ, Osoba D, Kris MG, Kirkbride P, Hesketh PJ, Chinnery LW, Clark-Snow R et al (1999) Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. J Clin Oncol 17:2971","journal-title":"J Clin Oncol"},{"key":"3071_CR52","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1200\/JCO.1997.15.1.103","volume":"15","author":"PJ Hesketh","year":"1997","unstructured":"Hesketh PJ, Kris MG, Grunberg SM, Beck T, Hainsworth JD, Harker G, Aapro MS, Gandara D, Lindley CM (1997) Proposal for classifying the acute emetogenicity of cancer chemotherapy. J Clin Oncol 15:103\u2013109","journal-title":"J Clin Oncol"},{"key":"3071_CR53","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0885-3924(00)00159-7","volume":"20","author":"JA Roscoe","year":"2000","unstructured":"Roscoe JA, Morrow GR, Hickok JT et al (2000) Nausea and vomiting remain a significant clinical problem: trends over time in controlling chemotherapy-induced nausea and vomiting in 1413 patients treated in community clinical practices. J Pain Symptom Manag 20:113\u2013121","journal-title":"J Pain Symptom Manag"},{"key":"3071_CR54","doi-asserted-by":"publisher","first-page":"4472","DOI":"10.1200\/JCO.2006.05.6382","volume":"24","author":"B Bloechl-Daum","year":"2006","unstructured":"Bloechl-Daum B, Deuson RR, Mavros P, Hansen M, Herrstedt J (2006) Delayed nausea and vomiting continue to reduce patients\u2019 quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment. J Clin Oncol 24:4472\u20134478","journal-title":"J Clin Oncol"},{"key":"3071_CR55","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1002\/cncr.20230","volume":"100","author":"SM Grunberg","year":"2004","unstructured":"Grunberg SM, Deuson RR, Mavros P, Geling O, Hansen M, Cruciani G, Daugaard G (2004) Incidence of chemotherapy\u2010induced nausea and emesis after modern antiemetics. Cancer 100:2261\u20132668","journal-title":"Cancer"},{"issue":"8","key":"3071_CR56","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1093\/annonc\/mds021","volume":"23","author":"M Aapro","year":"2012","unstructured":"Aapro M, Molassiotis A, Dicato M, Pel\u00e1ez I, Rodr\u00edguez-Lescure \u00c1, Pastorelli D, PEER investigators (2012) The effect of guideline-consistent antiemetic therapy on chemotherapy-induced nausea and vomiting (CINV): the Pan European Emesis Registry (PEER). Ann Oncol 23(8):1986\u20131992, mds021","journal-title":"Ann Oncol"},{"key":"3071_CR57","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00520-012-1493-9","volume":"21","author":"C Farrell","year":"2013","unstructured":"Farrell C, Brearley SG, Pilling M, Molassiotis A (2013) The impact of chemotherapy-related nausea on patients\u2019 nutritional status, psychological distress and quality of life. Support Care Cancer 21:59\u201366","journal-title":"Support Care Cancer"},{"key":"3071_CR58","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s00520-012-1574-9","volume":"21","author":"C Pirri","year":"2013","unstructured":"Pirri C, Bayliss E, Trotter J, Olver IN, Katris P, Drummond P, Bennett R (2013) Nausea still the poor relation in antiemetic therapy? The impact on cancer patients\u2019 quality of life and psychological adjustment of nausea, vomiting and appetite loss, individually and concurrently as part of a symptom cluster. Support Care Cancer 21:735\u2013748","journal-title":"Support Care Cancer"},{"key":"3071_CR59","first-page":"855","volume":"20","author":"K Tamura","year":"2015","unstructured":"Tamura K, Aiba K, Saeki T, Nakanishi Y, Kamura T, Baba H, Kitajima M (2015) Testing the effectiveness of antiemetic guidelines: results of a prospective registry by the CINV Study Group of Japan. Int J Cancer Oncol 20:855\u2013865, 1\u201311","journal-title":"Int J Cancer Oncol"},{"key":"3071_CR60","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1111\/ner.12303","volume":"18","author":"HS Sallam","year":"2015","unstructured":"Sallam HS, Song J, Chen JZ (2015) Electroacupuncture via chronically implanted electrodes: potential treatment for chemotherapy-induced delayed emesis. Neuromodulation 18:494\u2013498","journal-title":"Neuromodulation"},{"key":"3071_CR61","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1038\/bjc.1996.499","volume":"74","author":"TJ Hursti","year":"1996","unstructured":"Hursti TJ, Avall-Lundqvist E, B\u00f6rjeson S, Fredrikson M, F\u00fcrst CJ, Steineck G, Peterson C (1996) Impact of tumour burden on chemotherapy-induced nausea and vomiting. Br J Cancer 74:1114\u20131119","journal-title":"Br J Cancer"},{"key":"3071_CR62","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1007\/s00520-013-1843-2","volume":"21","author":"A Molassiotis","year":"2013","unstructured":"Molassiotis A, Stamataki Z, Kontopantelis E (2013) Development and preliminary validation of a risk prediction model for chemotherapy-related nausea and vomiting. Support Care Cancer 21:2759\u20132767","journal-title":"Support Care Cancer"},{"key":"3071_CR63","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s10549-009-0447-5","volume":"119","author":"Y Liu","year":"2010","unstructured":"Liu Y, Diamant AL, Thind A, Maly RC (2010) Validity of self-reports of breast cancer treatment in low-income, medically underserved women with breast cancer. Breast Cancer Res Treat 119:745\u2013751","journal-title":"Breast Cancer Res Treat"},{"key":"3071_CR64","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.canep.2013.05.010","volume":"37","author":"AM McCarthy","year":"2013","unstructured":"McCarthy AM, McGuire E, Bristol M, Fredricks T, Domchek SM, Armstrong K (2013) Agreement of self-reported hormone receptor status with cancer registry data in young breast cancer patients. Cancer Epidemiol 37:601\u2013605","journal-title":"Cancer Epidemiol"},{"key":"3071_CR65","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/1471-2288-11-72","volume":"11","author":"V Gupta","year":"2011","unstructured":"Gupta V, Gu K, Chen Z, Lu W, Shu XO, Zheng Y (2011) Concordance of self-reported and medical chart information on cancer diagnosis and treatment. BMC Med Res Methodol 11:72","journal-title":"BMC Med Res Methodol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-015-3071-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-015-3071-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-015-3071-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-015-3071-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T15:21:09Z","timestamp":1589642469000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-015-3071-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,8]]},"references-count":65,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["3071"],"URL":"https:\/\/doi.org\/10.1007\/s00520-015-3071-4","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,8]]},"assertion":[{"value":"26 August 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they do not have competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This research study was granted exempt status by Institutional Review Boards of the University of Wisconsin and University of Pittsburgh.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of human rights"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"This study was supported by NINR T32 NR07102, NINR F31 NR07556, Oncology Nursing Society\/Ortho-Biotech; PEO Scholar Award, and NCI P30 CA047904.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}